Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations

The frequency of antipsychotic (AP) use during pregnancy has approximately doubled during the last decade. However, little is known about their safety for the developing fetus, and concerns have been raised about a potential association with congenital malformations. To examine the risk for congenit...

Full description

Saved in:

Bibliographic Details
Published in:	JAMA psychiatry (Chicago, Ill.) Vol. 73; no. 9; p. 938
Main Authors:	Huybrechts, Krista F, Hernández-Díaz, Sonia, Patorno, Elisabetta, Desai, Rishi J, Mogun, Helen, Dejene, Sara Z, Cohen, Jacqueline M, Panchaud, Alice, Cohen, Lee, Bateman, Brian T
Format:	Journal Article
Language:	English
Published:	United States 01.09.2016
Subjects:	Abnormalities, Drug-Induced - epidemiology Abnormalities, Drug-Induced - etiology Adult Antipsychotic Agents - adverse effects Antipsychotic Agents - therapeutic use Cohort Studies Female Heart Defects, Congenital - chemically induced Heart Defects, Congenital - epidemiology Humans Infant, Newborn Medicaid - statistics & numerical data Pregnancy Pregnancy Complications - drug therapy Pregnancy Complications - epidemiology Pregnancy Trimester, First Psychotic Disorders - drug therapy Psychotic Disorders - epidemiology Risk Risperidone - adverse effects Risperidone - therapeutic use United States Young Adult
ISSN:	2168-6238, 2168-6238
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!